 Sunad Rangarajan
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 10 | 2023 | 451 | 3.520 |
Why?
| | Myofibroblasts | 7 | 2022 | 120 | 1.610 |
Why?
| | Indoles | 3 | 2017 | 316 | 1.050 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 6 | 0.880 |
Why?
| | Lung | 9 | 2022 | 3664 | 0.820 |
Why?
| | Energy Metabolism | 2 | 2023 | 767 | 0.740 |
Why?
| | Pyridones | 2 | 2017 | 119 | 0.650 |
Why?
| | Bone Marrow | 1 | 2019 | 255 | 0.640 |
Why?
| | Pulmonary Fibrosis | 2 | 2019 | 303 | 0.610 |
Why?
| | Aging | 2 | 2017 | 1670 | 0.580 |
Why?
| | Fibrosis | 4 | 2023 | 483 | 0.550 |
Why?
| | Mitochondria | 3 | 2018 | 786 | 0.540 |
Why?
| | Metformin | 1 | 2018 | 295 | 0.500 |
Why?
| | Transforming Growth Factor beta1 | 6 | 2020 | 164 | 0.480 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 356 | 0.450 |
Why?
| | Restless Legs Syndrome | 2 | 2007 | 19 | 0.380 |
Why?
| | Fibroblasts | 3 | 2022 | 842 | 0.370 |
Why?
| | Fibronectins | 2 | 2020 | 114 | 0.310 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2007 | 56 | 0.280 |
Why?
| | Smad3 Protein | 2 | 2016 | 47 | 0.280 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 285 | 0.280 |
Why?
| | Developing Countries | 1 | 2007 | 255 | 0.260 |
Why?
| | Cells, Cultured | 4 | 2023 | 4077 | 0.260 |
Why?
| | Oxidative Stress | 2 | 2022 | 1178 | 0.250 |
Why?
| | Cellular Senescence | 1 | 2023 | 151 | 0.210 |
Why?
| | Humans | 17 | 2023 | 118974 | 0.190 |
Why?
| | Sirtuin 3 | 1 | 2021 | 60 | 0.180 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 576 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2020 | 108 | 0.180 |
Why?
| | Interleukin-33 | 1 | 2019 | 39 | 0.180 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2016 | 53 | 0.170 |
Why?
| | Adenylate Kinase | 1 | 2018 | 29 | 0.160 |
Why?
| | Bone Marrow Cells | 1 | 2019 | 273 | 0.160 |
Why?
| | Signal Transduction | 4 | 2019 | 4709 | 0.150 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 133 | 0.150 |
Why?
| | RNA Interference | 2 | 2016 | 460 | 0.150 |
Why?
| | Bleomycin | 1 | 2018 | 228 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2017 | 102 | 0.150 |
Why?
| | Spheroids, Cellular | 1 | 2017 | 56 | 0.140 |
Why?
| | Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.140 |
Why?
| | Enzyme Activation | 1 | 2018 | 828 | 0.140 |
Why?
| | Beclin-1 | 1 | 2016 | 11 | 0.140 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2016 | 10 | 0.140 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2016 | 57 | 0.140 |
Why?
| | Ubiquitin-Activating Enzymes | 1 | 2016 | 16 | 0.140 |
Why?
| | Cellular Reprogramming | 1 | 2016 | 85 | 0.140 |
Why?
| | Cell Movement | 1 | 2020 | 896 | 0.140 |
Why?
| | Drug Approval | 1 | 2016 | 77 | 0.130 |
Why?
| | Collagen Type I | 1 | 2016 | 114 | 0.130 |
Why?
| | Caveolin 1 | 1 | 2015 | 23 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 190 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 304 | 0.120 |
Why?
| | Transfection | 1 | 2016 | 888 | 0.120 |
Why?
| | Lung Injury | 1 | 2016 | 210 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 292 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 827 | 0.110 |
Why?
| | Animals | 5 | 2022 | 33381 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4908 | 0.110 |
Why?
| | Phosphorylation | 1 | 2016 | 1633 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1945 | 0.100 |
Why?
| | India | 2 | 2007 | 141 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2016 | 1055 | 0.090 |
Why?
| | Mice | 2 | 2022 | 15520 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2018 | 3730 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2016 | 2657 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2015 | 1753 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2007 | 17 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2015 | 2275 | 0.080 |
Why?
| | Menorrhagia | 1 | 2007 | 14 | 0.070 |
Why?
| | Iron-Binding Proteins | 1 | 2007 | 38 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2445 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2007 | 307 | 0.070 |
Why?
| | Blood Donors | 1 | 2007 | 109 | 0.070 |
Why?
| | Reference Values | 1 | 2007 | 774 | 0.070 |
Why?
| | Time Factors | 1 | 2016 | 6412 | 0.060 |
Why?
| | Urban Population | 1 | 2007 | 409 | 0.060 |
Why?
| | Aged | 1 | 2022 | 19657 | 0.060 |
Why?
| | Up-Regulation | 2 | 2016 | 872 | 0.060 |
Why?
| | Cell Line | 2 | 2020 | 2707 | 0.050 |
Why?
| | Erythrocytes | 1 | 2007 | 641 | 0.050 |
Why?
| | A549 Cells | 1 | 2020 | 48 | 0.050 |
Why?
| | Peroxidase | 1 | 2020 | 170 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2007 | 4552 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2020 | 186 | 0.040 |
Why?
| | Tyrosine | 1 | 2020 | 233 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2490 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2007 | 2674 | 0.040 |
Why?
| | Male | 3 | 2018 | 57801 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 940 | 0.040 |
Why?
| | Genes, Developmental | 1 | 2016 | 2 | 0.040 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2016 | 24 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2020 | 446 | 0.040 |
Why?
| | Gene Expression | 1 | 2021 | 1489 | 0.030 |
Why?
| | Electron Transport | 1 | 2015 | 101 | 0.030 |
Why?
| | Hedgehog Proteins | 1 | 2016 | 175 | 0.030 |
Why?
| | Smad Proteins | 1 | 2015 | 39 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 239 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 311 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1233 | 0.030 |
Why?
| | Glycolysis | 1 | 2015 | 224 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2016 | 613 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 627 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2016 | 462 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2680 | 0.030 |
Why?
| | Biopsy | 1 | 2017 | 1079 | 0.030 |
Why?
| | Precision Medicine | 1 | 2017 | 363 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 586 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1691 | 0.030 |
Why?
| | Cell Survival | 1 | 2015 | 1047 | 0.030 |
Why?
| | Middle Aged | 2 | 2007 | 27617 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1597 | 0.020 |
Why?
| | Female | 3 | 2020 | 61565 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3171 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1715 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2874 | 0.020 |
Why?
| | Adult | 2 | 2007 | 31512 | 0.020 |
Why?
| | Research Design | 1 | 2007 | 969 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2326 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 4708 | 0.010 |
Why?
|
|
Rangarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|